Society for Clinical Vascular Surgery
November 04, 2009

Surgical Management of Tumors Involving the Aorta and Major Arterial Structures

Back to Annual Meeting
Back to Program
Susanne G. Carpenter, MD1, William B. Stone, MD1, Thomas C. Bower, MD2, Richard J. Fowl, MD1, Samuel R. Money, MD1.
1Mayo Clinic Arizona, Phoenix, AZ, USA, 2Mayo Clinic Rochester, Rochester, MN, USA.

Objectives:
This study investigates surgical management of tumors arising from or involving the aorta and major arterial structures.
Methods:
A single institutional review of all patients undergoing arterial resection for tumors involving the aorta or major vascular structures from January 1992-May 2009 was performed. Patients with tumors abutting arteries without necessitating arterial resection and those involving only venous structures were excluded.
Results:
60 patients underwent arterial resection for the management of neoplasms. The iliac arteries were most commonly resected with sarcomatous pathology most commonly observed (39 patients, 65%).

Arterial Structure Involvedn (%)
n = 60
Path margins free of tumorReconstructionMean Estimated Blood Loss (range)30-day mortality
Aorta12 (20%)6/12 (50%)9/12 (75%)2.4L (0.76 - 6.5L)2/12 (17%)
Carotid6 (10%)6/6 (100%)4/6 (66%)0.3L (0.05 - 0.7L)0/6 (0%)
External/Common Iliac16 (27%)12/16 (75%)11/16 (69%)5.3L (0.3 - 25L)0/16 (0%)
Internal Iliac18 (30%)15/18 (83%)0/18 (0%)3.6L (0.7 - 14L)1/18 (6%)
Superficial Femoral3 (5%)2/3 (66%)2/3 (66%)0.88L (0.45-1.3L)0/3 (0%)
Miscellaneous5 (8%)3/5 (60%)4/5 (80%)Data unavailable0/5 (0%)

14 patients (23%) required return to the operating room. Mean follow-up was 16.6 months (range 0-122 months). 32 patients had greater than one year follow-up. Among those, 1-year overall survival was 69% with disease-free survival of 38%.
Conclusions:
Resection of tumors involving the aorta and major arterial structures provides a reasonable option for treatment, but with significant peri-operative morbidity. In selected patients, this aggressive surgical option should not be overlooked.
Back to Annual Meeting
Back to Program